Lazard Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80K | Sell |
5,461
-4,457
| -45% | -$65.3K | ﹤0.01% | 1913 |
|
|
2025
Q1 | $177K | Buy |
9,918
+4,201
| +73% | +$75K | ﹤0.01% | 1656 |
|
|
2024
Q4 | $99K | Buy |
+5,717
| New | +$99K | ﹤0.01% | 1800 |
|
|
2023
Q4 | – | Sell |
-11,862
| Closed | -$106K | – | 2489 |
|
|
2023
Q3 | $106K | Sell |
11,862
-45,038
| -79% | -$402K | ﹤0.01% | 1612 |
|
|
2023
Q2 | $873K | Sell |
56,900
-44,515
| -44% | -$683K | ﹤0.01% | 1017 |
|
|
2023
Q1 | $2.28M | Sell |
101,415
-24,174
| -19% | -$543K | ﹤0.01% | 894 |
|
|
2022
Q4 | $2.64M | Buy |
+125,589
| New | +$2.64M | ﹤0.01% | 857 |
|
|
2022
Q3 | – | Sell |
-703
| Closed | -$17K | – | 2575 |
|
|
2022
Q2 | $17K | Sell |
703
-51
| -7% | -$1.23K | ﹤0.01% | 2153 |
|
|
2022
Q1 | $19K | Sell |
754
-4,299
| -85% | -$108K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $156K | Buy |
5,053
+578
| +13% | +$17.8K | ﹤0.01% | 1328 |
|
|
2021
Q3 | $108K | Buy |
+4,475
| New | +$108K | ﹤0.01% | 1401 |
|
|
2021
Q1 | – | Sell |
-3,616
| Closed | -$98K | – | 2030 |
|
|
2020
Q4 | $98K | Hold |
3,616
| – | – | ﹤0.01% | 1189 |
|
|
2020
Q3 | $66K | Sell |
3,616
-1,970
| -35% | -$36K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $114K | Buy |
5,586
+1,267
| +29% | +$25.9K | ﹤0.01% | 992 |
|
|
2020
Q1 | $63K | Buy |
+4,319
| New | +$63K | ﹤0.01% | 1111 |
|
|
2019
Q4 | – | Sell |
-875
| Closed | -$10K | – | 1669 |
|
|
2019
Q3 | $10K | Buy |
+875
| New | +$10K | ﹤0.01% | 1309 |
|